ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Gallo To Say, For Now, DeVita Says: Core Grants Face Big Cut

March 18, 1988

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014